62cu-thiosemicarbazone
Small moleculeexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2008 (NCT00714142)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiodepletion
radiodepletion
Chemistry & pharmacology
- Payload
- 62-copper
Oral
No
Parenteral
No
Topical
No
Also known as
- 62cu-thiosemicarbazone
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01502228 | N/A | Oct 1, 2011 | Indiana University |
| NCT00714142 | Phase 2 | Aug 1, 2008 | Proportional Technologies, Inc., University of Wisconsin |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Indiana University | Academic/Hospital | 1 | 1 | 1 | 2011 |
| Proportional Technologies, Inc. | For profit | 1 | 1 | 1 | 2008 |
| University of Wisconsin | Academic/Hospital | 1 | 0 | 1 | 2008 |
3 organizations
Page 1 / 1